NO169067C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter

Info

Publication number: NO169067C
Authority: NO; Norway
Prior art keywords: indoles; aminoalkyl; intermediates; carbonyl; preparation
Prior art date: 1984-08-06

Application number

NO853066A

Other languages

English (en)

Other versions

NO169067B (no

NO853066L (no

Inventor

Malcolm Rice Bell

Original Assignee

Sterling Drug Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-08-06

Filing date

1985-08-02

Publication date

1992-05-06

1985-08-02 Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc

1986-02-07 Publication of NO853066L publication Critical patent/NO853066L/no

1990-07-25 Priority to NO903304A priority Critical patent/NO903304D0/no

1990-07-25 Priority to NO903306A priority patent/NO903306D0/no

1990-07-25 Priority to NO903305A priority patent/NO903305D0/no

1992-01-27 Publication of NO169067B publication Critical patent/NO169067B/no

1992-05-06 Publication of NO169067C publication Critical patent/NO169067C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Pain & Pain Management (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO853066A 1984-08-06 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter NO169067C (no)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
NO903304A NO903304D0 (no)	1984-08-06	1990-07-25	Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903306A NO903306D0 (no)	1984-08-06	1990-07-25	Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903305A NO903305D0 (no)	1984-08-06	1990-07-25	Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US63793184A	1984-08-06	1984-08-06

Publications (3)

Publication Number	Publication Date
NO853066L NO853066L (no)	1986-02-07
NO169067B NO169067B (no)	1992-01-27
NO169067C true NO169067C (no)	1992-05-06

Family

ID=24557949

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO853066A NO169067C (no)	1984-08-06	1985-08-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter

Country Status (20)

Country	Link
EP (1)	EP0171037B1 (no)
JP (1)	JPH0670010B2 (no)
KR (1)	KR870000548B1 (no)
AR (1)	AR244665A1 (no)
AT (1)	ATE77371T1 (no)
AU (1)	AU574817B2 (no)
DE (1)	DE3586224T2 (no)
DK (1)	DK170279B1 (no)
ES (5)	ES8609246A1 (no)
FI (1)	FI852973L (no)
GR (1)	GR851937B (no)
IE (1)	IE57863B1 (no)
IL (1)	IL75966A (no)
MX (4)	MX160612A (no)
MY (1)	MY101186A (no)
NO (1)	NO169067C (no)
NZ (3)	NZ225466A (no)
PH (2)	PH23498A (no)
PT (1)	PT80919B (no)
ZA (1)	ZA855923B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8623819D0 (en) *	1986-10-03	1986-11-05	Glaxo Group Ltd	Heterocyclic compounds
US4840950A (en) *	1987-02-11	1989-06-20	Sterling Drug Inc.	4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles
US5068234A (en) *	1990-02-26	1991-11-26	Sterling Drug Inc.	3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9011335D0 (en) *	1990-05-21	1990-07-11	Fujisawa Pharmaceutical Co	Indolebutyric acid derivatives and process for preparation thereof
US5312829A (en) *	1990-05-21	1994-05-17	Fujisawa Pharmaceutical Co., Ltd.	Indole derivatives
GB9204365D0 (en) *	1992-02-28	1992-04-08	Pfizer Ltd	Indoles
TW270114B (no) *	1993-10-22	1996-02-11	Hoffmann La Roche
US5486525A (en) *	1993-12-16	1996-01-23	Abbott Laboratories	Platelet activating factor antagonists: imidazopyridine indoles
CA2382116A1 (en)	1999-08-26	2001-03-08	Fujisawa Pharmaceutical Co., Ltd.	Process for the preparation of indole derivatives or salts thereof
JP6493786B2 (ja) *	2015-01-06	2019-04-03	パナソニックＩｐマネジメント株式会社	免疫原、それを用いた抗体の製造方法、及び、そのモノクローナル抗体
JP6435505B2 (ja) *	2015-01-13	2018-12-12	パナソニックＩｐマネジメント株式会社	化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3238215A (en) *	1963-10-17	1966-03-01	Sterling Drug Inc	1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217011A (en) *	1965-05-07	1965-11-09	Sterling Drug Inc	1-(indolyglyoxalyl)-piperidines
US3489770A (en) *	1967-12-18	1970-01-13	American Home Prod	1-cyclo(lower)alkanoyl or admantanylcarbonyl - 3 - (2-substituted ethyl)indoles
GB1374414A (en) *	1972-06-12	1974-11-20	Sterling Drug Inc	1-acyl-3-amino-alkyl-indoles and their preparation
GB1436771A (en) *	1973-02-16	1976-05-26	Labaz	Indole derivatives and process for preparing the same
FR2354766A1 (fr) *	1976-06-17	1978-01-13	Labaz	Derives n-aminoalkyles d'indole et procedes pour les preparer
ES8605232A1 (es) *	1984-02-07	1986-03-16	Pfizer	Un procedimiento para la preparacion de compuestos de 2-o- xindol

1985
- 1985-07-29 PH PH32579A patent/PH23498A/en unknown
- 1985-07-30 IL IL75966A patent/IL75966A/xx not_active IP Right Cessation
- 1985-08-01 NZ NZ225466A patent/NZ225466A/xx unknown
- 1985-08-01 EP EP85109689A patent/EP0171037B1/en not_active Expired - Lifetime
- 1985-08-01 NZ NZ212953A patent/NZ212953A/xx unknown
- 1985-08-01 DE DE8585109689T patent/DE3586224T2/de not_active Expired - Fee Related
- 1985-08-01 FI FI852973A patent/FI852973L/fi not_active Application Discontinuation
- 1985-08-01 NZ NZ225467A patent/NZ225467A/xx unknown
- 1985-08-01 AT AT85109689T patent/ATE77371T1/de not_active IP Right Cessation
- 1985-08-02 IE IE1930/85A patent/IE57863B1/en not_active IP Right Cessation
- 1985-08-02 NO NO853066A patent/NO169067C/no not_active IP Right Cessation
- 1985-08-05 AU AU45764/85A patent/AU574817B2/en not_active Ceased
- 1985-08-05 KR KR1019850005643A patent/KR870000548B1/ko not_active IP Right Cessation
- 1985-08-05 DK DK354485A patent/DK170279B1/da not_active IP Right Cessation
- 1985-08-05 ES ES545894A patent/ES8609246A1/es not_active Expired
- 1985-08-06 GR GR851937A patent/GR851937B/el unknown
- 1985-08-06 ZA ZA855923A patent/ZA855923B/xx unknown
- 1985-08-06 MX MX8194A patent/MX160612A/es unknown
- 1985-08-06 JP JP60173058A patent/JPH0670010B2/ja not_active Expired - Fee Related
- 1985-08-06 AR AR85301206A patent/AR244665A1/es active
- 1985-08-06 PT PT80919A patent/PT80919B/pt unknown
1986
- 1986-03-12 ES ES552912A patent/ES8800149A1/es not_active Expired
- 1986-03-12 ES ES552911A patent/ES8800902A1/es not_active Expired
- 1986-03-12 ES ES552910A patent/ES8801203A1/es not_active Expired
- 1986-03-12 ES ES552909A patent/ES8800901A1/es not_active Expired
1987
- 1987-01-26 PH PH34765A patent/PH25360A/en unknown
- 1987-09-28 MY MYPI87002036A patent/MY101186A/en unknown
1989
- 1989-01-04 MX MX1443289A patent/MX14432A/es unknown
- 1989-01-04 MX MX1442989A patent/MX14429A/es unknown
- 1989-01-04 MX MX1443189A patent/MX14431A/es unknown

Also Published As

Publication number	Publication date
FI852973A0 (fi)	1985-08-01
IE57863B1 (en)	1993-05-05
ATE77371T1 (de)	1992-07-15
PH25360A (en)	1991-05-13
ES545894A0 (es)	1986-07-16
ES552909A0 (es)	1987-12-01
ES552910A0 (es)	1987-12-16
JPS6147463A (ja)	1986-03-07
AU574817B2 (en)	1988-07-14
DK170279B1 (da)	1995-07-24
ES8609246A1 (es)	1986-07-16
DE3586224T2 (de)	1993-01-28
PT80919B (pt)	1987-09-30
ES552912A0 (es)	1987-10-16
MX14429A (es)	1993-09-01
EP0171037A3 (en)	1987-08-26
NZ225466A (en)	1990-02-26
MX160612A (es)	1990-03-28
KR860001805A (ko)	1986-03-22
IL75966A (en)	1989-08-15
NZ225467A (en)	1990-02-26
AU4576485A (en)	1986-02-13
KR870000548B1 (ko)	1987-03-18
ES8800149A1 (es)	1987-10-16
ES8800902A1 (es)	1987-12-01
PH23498A (en)	1989-08-16
DE3586224D1 (de)	1992-07-23
DK354485D0 (da)	1985-08-05
ES8801203A1 (es)	1987-12-16
IE851930L (en)	1986-02-06
NO169067B (no)	1992-01-27
ES8800901A1 (es)	1987-12-01
EP0171037A2 (en)	1986-02-12
MY101186A (en)	1991-07-31
AR244665A1 (es)	1993-11-30
EP0171037B1 (en)	1992-06-17
MX14431A (es)	1993-08-01
MX14432A (es)	1993-08-01
NZ212953A (en)	1990-02-26
IL75966A0 (en)	1985-12-31
GR851937B (no)	1985-12-05
ZA855923B (en)	1986-03-26
JPH0670010B2 (ja)	1994-09-07
ES552911A0 (es)	1987-12-01
PT80919A (en)	1985-09-01
NO853066L (no)	1986-02-07
DK354485A (da)	1986-02-07
FI852973L (fi)	1986-02-07

Legal Events

Date	Code	Title	Description
2005-05-02	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO853046L (no)	1986-02-03	Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no)	1990-05-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO161370C (no)	1989-08-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO853293L (no)	1986-02-24	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO862477D0 (no)	1986-06-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO870075D0 (no)	1987-01-08	Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO852885L (no)	1986-01-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater.
NO165023C (no)	1990-12-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO171269C (no)	1993-02-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO157146C (no)	1988-01-27	Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin.
NO864674D0 (no)	1986-11-21	Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO871588L (no)	1987-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO168355C (no)	1992-02-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO162721C (no)	1990-02-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO165592C (no)	1991-03-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiofener og benzofuraner.
NO862373D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO863671L (no)	1987-03-17	Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO864130D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO864131D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO164897C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO169067C (no)	1992-05-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter
NO862534L (no)	1986-12-29	Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no)	1990-12-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.